{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:09:27Z","timestamp":1792444167254,"version":"4.5.0"},"reference-count":11,"publisher":"Cambridge University Press (CUP)","issue":"S1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"unspecified","delay-in-days":357,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Long-acting injectable (LAI) antipsychotics are not routinely offered and, thus, are underutilized despite their many advantages over oral formulations. In this special collection of articles, the reader will find overviews of the art and science of prescribing this important treatment option. Guidance is offered regarding incorporating LAIs in treatment planning, including inpatient, outpatient, and jail settings. Reviewed is the evidence surrounding the use of LAIs for patients in their first episode of schizophrenia, as well as switching from oral agents and other common issues that come up in day-to-day practice. Also provided is a comprehensive summary of each of the currently available formulations of LAIs, and some pragmatic reasons why one would be considered over another. In the end, the reader will come away with the notion that LAIs are not a \u201clast resort\u201d but an important and useful treatment modality that ought to be considered more often.<\/jats:p>","DOI":"10.1017\/s1092852925100722","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T09:22:48Z","timestamp":1766568168000},"page":"S43-S44","source":"Crossref","is-referenced-by-count":1,"title":["Introducing a special collection of CME articles about long-acting injectable antipsychotics"],"prefix":"10.1017","volume":"30","author":[{"given":"Leslie","family":"Citrome","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03dkvy735","id-type":"ROR","asserted-by":"publisher"}],"name":"New York Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"S1092852925100722_r11","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12142"},{"key":"S1092852925100722_r3","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13379"},{"key":"S1092852925100722_r6","article-title":"Understanding long-acting injectable antipsychotics in the context of treatment planning: crafting a strategy","author":"Citrome","journal-title":"CNS Spectr"},{"key":"S1092852925100722_r9","article-title":"Solutions to common issues in the use of LAIs","author":"Saklad","journal-title":"CNS Spectr"},{"key":"S1092852925100722_r2","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12571"},{"key":"S1092852925100722_r7","first-page":"e66","article-title":"Long-acting injectable antipsychotics for patients with first-episode and early-phase schizophrenia: still not considered often enough","volume":"30","author":"Correll","year":"2025","journal-title":"CNS Spectr"},{"key":"S1092852925100722_r4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.177901"},{"key":"S1092852925100722_r8","article-title":"Prescribing LAIs: from completing the first injection to going steady","author":"Grady","journal-title":"CNS Spectr"},{"key":"S1092852925100722_r1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12420"},{"key":"S1092852925100722_r5","article-title":"Lies and LAIs: why accuracy of information is the key to understanding the benefits and the resistance to using long-acting formulations","author":"Weiden","journal-title":"CNS Spectr"},{"key":"S1092852925100722_r10","first-page":"1","article-title":"Choosing amongst the long-acting injectable antipsychotics: an evidence-based pragmatic guide","volume":"18","author":"Citrome","year":"2025","journal-title":"CNS Spectr"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852925100722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:31:31Z","timestamp":1771248691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852925100722\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":11,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2025]]}},"alternative-id":["S1092852925100722"],"URL":"https:\/\/doi.org\/10.1017\/s1092852925100722","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}